| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/06/2005 | WO2005000888A3 NOVEL β-ACTIN AND RPS21 PROMOTERS AND USES THEREOF |
| 05/06/2005 | WO2004110512A3 A method for cell implantation |
| 05/06/2005 | WO2004098377A3 Methods and compositions for diagnosis and therapy of parkin-associated disorders |
| 05/06/2005 | WO2004093830A3 Model for neurodegenerative disorders |
| 05/06/2005 | WO2004091495A3 Compositions and methods related to production of erythropoietin |
| 05/06/2005 | WO2004084807A3 Micro-cluster compositions |
| 05/06/2005 | WO2004081533A3 Vault and vault-like carrier molecules |
| 05/06/2005 | WO2004078776A3 Ny-eso-1 peptides which bind to class ii molecules and uses thereof |
| 05/06/2005 | WO2004053080A3 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media |
| 05/06/2005 | WO2004041061A3 Substrates, devices, and methods for cellular assays |
| 05/06/2005 | WO2004035537A8 Antibodies that bind cell-associated ca 125/o772p and methods of use thereof |
| 05/06/2005 | WO2004018619A3 P53 binding t cell receptor molecules and uses thereof |
| 05/06/2005 | WO2004007749A3 Methods and systems for extended in vitro culture of neuronal cells |
| 05/06/2005 | WO2004000217A3 Vaccines for suppressing ige-mediated allergic disease and methods for using the same |
| 05/06/2005 | WO2003068146A3 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/06/2005 | WO2003062394A3 Methods and compositions for rna interference |
| 05/06/2005 | CA2826733A1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
| 05/06/2005 | CA2547514A1 Method for screening genomic dna fragments |
| 05/06/2005 | CA2543374A1 Method and bioreactor for the cultivation and stimulation of three-dimensional vital and mechanically-resistant cell transplants |
| 05/06/2005 | CA2543200A1 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 05/06/2005 | CA2543189A1 In vivo gene therapy of parkinson's disease |
| 05/06/2005 | CA2543002A1 Method for inducing a specific rnai activity in cells and nucleic acids for carrying out said method |
| 05/06/2005 | CA2542881A1 Antibody with an optimized fucose content/galactose content ratio |
| 05/06/2005 | CA2542686A1 Colorectal cancer antigen |
| 05/06/2005 | CA2542426A1 Methods, compositions and devices for inducing stasis in cells |
| 05/06/2005 | CA2542017A1 Vitamin k epoxide recycling polypeptide vkorc1, a therapeutic target of coumarin and their derivatives |
| 05/06/2005 | CA2540023A1 Hepatocellular carcinoma specific promoter and uses thereof |
| 05/06/2005 | CA2535836A1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
| 05/05/2005 | US20050097639 Abiotic stress tolerance protein for use as tool in generating drought resistant crop plants |
| 05/05/2005 | US20050097638 Transcriptional regulation of plant biomass and abiotic stress tolerance |
| 05/05/2005 | US20050097635 Nucleotide sequences coding crystal protein for use in generating insect resistant crop plants; biological pest control |
| 05/05/2005 | US20050097627 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 05/05/2005 | US20050096731 Cell therapy via body lumens for localized delivery of cells by a stent-like expandable body seeded with cells and having a microstructure to project outwardly from the end to penetrate a tissue wall for delivery; increased anchorage of the tube with reduced migration; time-relase agents; drug delivery |
| 05/05/2005 | US20050096458 GENSET polynucleotides and polypeptides used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, expression vectors production; screening/diagnosis assays for abnormal GENSET expression and/or biological activity; gene therapy; genomics |
| 05/05/2005 | US20050096457 Peptide substrates and fusion polypeptide substrates comprising a beta -secretase cleavage site wherein a human Aspartyl protease cleaves the peptide between P1 and P1, the rate of which cleavage is used to identify modulators of Alzeimer's disease, neurofibrillary tangles, gliosis and neuronal loss |
| 05/05/2005 | US20050096285 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 05/05/2005 | US20050096277 Methods of prevention and treatment using apolipoprotein analogues |
| 05/05/2005 | US20050096259 Neutrophil activation by immune response modifier compounds |
| 05/05/2005 | US20050095807 Silicon buffered shallow trench isolation for strained silicon processes |
| 05/05/2005 | US20050095713 Vectors for gene mutagenesis and gene discovery |
| 05/05/2005 | US20050095712 Mutations caused by activation-induced cytidine deaminase |
| 05/05/2005 | US20050095711 Bioreactor for growing engineered tissue |
| 05/05/2005 | US20050095708 Using cell surface marker as tool in identification and separation of progenitor cell populations |
| 05/05/2005 | US20050095707 Using mixture comprising embryonic stem cells, neurotrophins and either cyclic adenosine monophosphate (cAMP) to propagate nervous system tissues for use in treatment of neurodegenerative disorders; regenerative medicine; tissue engineering |
| 05/05/2005 | US20050095706 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
| 05/05/2005 | US20050095705 Cell comprising replication-competent adenovirus vector for use as tool in generating gene therapeutic vectors; tissue directed therapy |
| 05/05/2005 | US20050095704 Using nuclear transplantaion to transfer preferential nuclear material into enucleated animal oocyte; tissue engineering; gene therapy |
| 05/05/2005 | US20050095703 Generating progenitor cells for use in prevention and treatment of cell proliferative, neurodegenerative and pancreatic disorders; regenerative medicine; tissue engineering |
| 05/05/2005 | US20050095702 In vitro generation of GABAergic neurons from embryonic stem cells and their use in the treatment of neurological disorders |
| 05/05/2005 | US20050095701 Transplanting conditionally-immortalized dorsal root ganglion progenitor cells into mammal to generate peripheral nervous system (PNS) for treatment and prevention of nervous system disorders |
| 05/05/2005 | US20050095700 Method for maintaining low shear in a bioprocessing system |
| 05/05/2005 | US20050095695 Nanofibrillar structure and applications including cell and tissue culture |
| 05/05/2005 | US20050095681 Intracellular modulators of apoptopic cell death pathways |
| 05/05/2005 | US20050095675 Mucin peptide with immunoenhancing properties |
| 05/05/2005 | US20050095671 Nucleotide sequences coding splice variant of ubiquination regulatory protein for use in prevention and treatment of neurodegenerative disorders |
| 05/05/2005 | US20050095667 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins |
| 05/05/2005 | US20050095664 Printing growth medium for culture and analysis of biological material |
| 05/05/2005 | US20050095650 screening for an agent that modulates capsaicin receptor function |
| 05/05/2005 | US20050095612 isolated antibody that specifically binds to polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 05/05/2005 | US20050095584 Method for determining early HCV seroconversion |
| 05/05/2005 | US20050095581 Viral polypeptide for use as tool in generating immunoreactive particle for diagnosis, prevention and treatment of viral infection |
| 05/05/2005 | US20050095315 Process for the production of alcoholic beverages using maltseed |
| 05/05/2005 | US20050095258 Vaccine inhibiting gonadotropin releasing hormone activity in cattle and protecting against bovine herpes virus type 1; polynucleotides, vectors, transformed cells |
| 05/05/2005 | US20050095256 Nucleotide sequence encoding merozoite surface protein-1 of plasmodium strain with reduced adenine and thymine; vectors, organisms, host cells |
| 05/05/2005 | US20050095234 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5 |
| 05/05/2005 | US20050095231 Transduction; gene therapy; replacing capsid with chimeric molecule containing heterologous trimerization motif and stabilized scFv ligand; host cells |
| 05/05/2005 | US20050095230 For treatment of cancer or virus infection (HIV) |
| 05/05/2005 | US20050095229 Comprises conduit connected to blood pool, cell culture for producing analyte (insulin, glucagons, and/or somatostatin), and concentration controller (integrated circuit) |
| 05/04/2005 | EP1528105A1 A solely pollen-specific promoter |
| 05/04/2005 | EP1528103A1 'Osteoclast-inhibitory factor' (OCIF) derived proteins and methods for producing the proteins |
| 05/04/2005 | EP1528102A2 Cloning and recombinant productions of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 05/04/2005 | EP1528101A1 Immortalized avian cell lines for virus production |
| 05/04/2005 | EP1527888A2 Printing growth medium for culture and analysis of biological material |
| 05/04/2005 | EP1527341A2 Interfacial biomaterials |
| 05/04/2005 | EP1527189A2 Mutant proteinase inhibitors and uses thereof |
| 05/04/2005 | EP1527185A1 Plastid transformation using modular vectors |
| 05/04/2005 | EP1527178A2 Novel class ii cytokine receptors and uses thereof |
| 05/04/2005 | EP1527177A2 Muc-1 antigen with reduced number of vntr repeat units |
| 05/04/2005 | EP1527176A2 Further novel forms of interfering rna molecules |
| 05/04/2005 | EP1527171A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 05/04/2005 | EP1527164A2 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor |
| 05/04/2005 | EP1527163A2 Preparation of type ii pneumocytes from stem cells |
| 05/04/2005 | EP1527161A2 Stem cells derived from adipous tissue and differentiated cells derived from said cells |
| 05/04/2005 | EP1527158A2 Advanced roller bottle system for cell and tissue culturing |
| 05/04/2005 | EP1527101A2 Specific antibodies for diagnosing heart failure |
| 05/04/2005 | EP1527100A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 05/04/2005 | EP1527084A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/04/2005 | EP1527080A2 Campylobacter glycans and glycopeptides |
| 05/04/2005 | EP1465493A4 Cultured and encapsulated pancreatic stem cells |
| 05/04/2005 | EP1442022A4 Polyamide modulators of cox2 transcription |
| 05/04/2005 | EP1362062B1 Concatameric immunoadhesion |
| 05/04/2005 | EP1297121B1 Purging of cells using viruses |
| 05/04/2005 | EP1261696B1 Rna polymerase mutants with increased thermostability |
| 05/04/2005 | EP1181355A4 A device and method for performing a biological modification of a fluid |
| 05/04/2005 | EP1124984A4 Host cells expressing recombinant human erythropoietin |
| 05/04/2005 | EP1037990B1 Human sel-10 polypeptides and polynucleotides that encode them |
| 05/04/2005 | EP0781340B1 Vaccine against group A Streptococcal infection |
| 05/04/2005 | EP0672139B1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/04/2005 | EP0456706B1 Molecular methods of hybrid seed production |
| 05/04/2005 | CN1613011A Signal system and elements used therein |